AAAAAA
Results: 1-25/80
Authors:
KHAN P
MCGOWN AT
DAWSON MJ
JAYSON G
PRENDIVILLE JA
PETTIT GR
CROWTHER D
Citation: P. Khan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE NOVEL ANTITUMORDRUG, BRYOSTATIN-1, INCORPORATING A SERUM EXTRACTION TECHNIQUE, Journal of chromatography B. Biomedical sciences and applications, 709(1), 1998, pp. 113-117
Authors:
LECESNE A
JUDSON J
CROWTHER D
SOMERS R
TURSZ T
KEIZER J
VANHOESEL D
BLAY Y
FRISCH J
VANGLABBEKE M
VANOOSTEROM AT
VERWEIJ J
Citation: A. Lecesne et al., IS OBTENTION OF PARTIAL-RESPONSE (PR) IN FRONT-LINE CHEMOTHERAPY CRITICAL TO IMPROVE OUTCOME OF METASTATIC SOFT-TISSUE SARCOMA (MSTS) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 556-556
Authors:
WEAVER A
CHANG J
WRIGLEY E
DEWYNTER E
WOLL PJ
LIND M
JENKINS B
GILL C
WILKINSON PM
PETTENGELL R
RADFORD JA
COLLINS CD
DEXTER TM
TESTA NG
CROWTHER D
Citation: A. Weaver et al., RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2601-2612
Authors:
LOEFFLER M
BROSTEANU O
HASENCLEVER D
SEXTRO M
ASSOULINE D
BARTOLUCCI AA
CASSILETH PA
CROWTHER D
DIEHL V
FISHER RI
HOPPE RT
JACOBS P
PATER JL
PAVLOVSKY S
THOMPSON E
WIERNIK P
Citation: M. Loeffler et al., METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE, Journal of clinical oncology, 16(3), 1998, pp. 818-829
Authors:
LUNDIN J
OSTERBORG A
BRITTINGER G
CROWTHER D
DOMBRET H
ENGERT A
EPENETOS A
GISSELBRECHT C
HUHN D
JAEGER U
THOMAS J
MARCUS R
NISSEN N
POYNTON C
RANKIN E
STAHEL R
UPPENKAMP M
WILLEMZE R
MELLSTEDT H
Citation: J. Lundin et al., CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3257-3263
Authors:
DOBSON LS
DUGGANKEEN M
RADFORD JA
STERN PL
MORGENSTERN GR
SCARFFE JH
CROWTHER D
Citation: Ls. Dobson et al., CAN INTERLEUKIN-2 IMMEDIATELY AFTER HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA BE A SAFE AND EFFECTIVE WAY OF CAUSING A GRAFT-VERSUS-LYMPHOMA EFFECT, British Journal of Cancer, 78, 1998, pp. 51-51
Authors:
DOBSON LS
DUGGANKEEN M
RADFORD JA
STERN PL
MORGENSTERN GR
SCARFFE HJ
CROWTHER D
Citation: Ls. Dobson et al., CYCLOSPORINE-A - CAN IT BE EFFECTIVELY GIVEN FROM THE DAY OF STEM-CELL RETURN IN PATIENTS WITH POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION, British Journal of Cancer, 78, 1998, pp. 52-52
Authors:
AABO K
ADAMS M
ADNITT P
ALBERTS DS
ATHANAZZIOU A
BARLEY V
BELL DR
BIANCHI U
BOLIS G
BRADY MF
BRODOVSKY HS
BRUCKNER H
BUYSE M
CANETTA R
CHYLAK V
COHEN CJ
COLOMBO N
CONTE PF
CROWTHER D
EDMONSON JH
GENNATAS C
GILBEY E
GORE M
GUTHRIE D
KAYE SB
LAING AH
LANDONI F
LEONARD RC
LEWIS C
LIU PY
MANGIONI C
MARSONI S
MEERPOHL H
OMURA GA
PARMAR MKB
PATER J
PECORELLI S
PRESTI M
SAUERBREI W
SKARLOS DV
SMALLEY RV
SOLOMON HJ
STEWART LA
STURGEON JFG
TATTERSALL MHN
WHARTON JT
HUININK WWT
TOMIROTTI M
TORRI W
TROPE C
TURBOW MM
VERMORKEN JB
WEBB MJ
WILBUR DW
WILLIAMS CJ
WILTSHAW E
YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
Authors:
LEE SM
RADFORD JA
DOBSON L
HUQ T
RYDER WDJ
PETTENGELL R
MORGENSTERN GR
SCARFFE JH
CROWTHER D
Citation: Sm. Lee et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL BENEFITS AT NO EXTRA COST, British Journal of Cancer, 77(8), 1998, pp. 1294-1299
Authors:
MCGOWN AT
JAYSON G
PETTIT GR
HARAN MS
WARD TH
CROWTHER D
Citation: At. Mcgown et al., BRYOSTATIN 1-TAMOXIFEN COMBINATIONS SHOW SYNERGISTIC EFFECTS ON THE INHIBITION OF GROWTH OF P388 CELLS IN-VITRO, British Journal of Cancer, 77(2), 1998, pp. 216-220
Authors:
MONAGHAN JM
COOK K
GARA D
CROWTHER D
Citation: Jm. Monaghan et al., DETERMINATION OF NITRITE AND NITRATE IN HUMAN SERUM, Journal of chromatography, 770(1-2), 1997, pp. 143-149
Authors:
RADFORD JA
EARDLEY A
WOODMAN C
CROWTHER D
Citation: Ja. Radford et al., FOLLOW-UP POLICY AFTER TREATMENT FOR HODGKINS-DISEASE - TOO MANY CLINIC VISITS AND ROUTINE TESTS - A REVIEW OF HOSPITAL RECORDS, BMJ. British medical journal, 314(7077), 1997, pp. 343-346
Authors:
CROWTHER D
Citation: D. Crowther, SHOULD HIGH-DOSE CHEMOTHERAPY BE USED IN THE TREATMENT OF SOFT-TISSUESARCOMA - ARBITER, European journal of cancer, 33(9), 1997, pp. 1359-1360
Authors:
WEAVER A
WOLL PJ
LIND M
GILL C
JENKINS B
DEXTER TM
TESTA NG
CROWTHER D
Citation: A. Weaver et al., STEM-CELL FACTOR (R-METHUSCF) IN COMBINATION WITH FILGRASTIM (R-METHUG-CSF) ENHANCES PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION FOLLOWING CHEMOTHERAPY - A RANDOMIZED STUDY, European journal of cancer, 33, 1997, pp. 7-7
Authors:
CROWTHER D
WEAVER A
Citation: D. Crowther et A. Weaver, A CLINICAL ROLE FOR STEM-CELL FACTOR (SCF) IN CANCER-PATIENT MANAGEMENT, European journal of cancer, 33, 1997, pp. 10-10
PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors:
OSTERBORG A
DYER MJS
BUNJES D
PANGALIS GA
BASTION Y
CATOVSKY D
MELLSTEDT H
RANKIN E
TSEKOURAS C
PANGALIS GA
CAVALLI F
SESSA C
HUHN D
MARCUS R
MAUGHAN T
POYNTON C
NISSEN N
CARNEY D
BRITTINGER G
UPPENKAMP M
ELONEN E
TEERENHOVI L",ENGERT,"WILLEMZE R
KLUINNELEMANS J
THOMAS J
EPENETOS AA
NETHERSELL A
DYER M
CATOVSKY D
DICATO M
BASTION Y
COIFFIER B
RANADA JMF
CROWTHER D
WOLL P
RAEMAKAERS J
DEPAUW B
DEGOS L",GISSELLBRECHT,"REIFFERS J
MELLSTEDT H
FASSAS A
ANAGNOSTOPOULOS A
BUNJES D
JAEGER U
STAHEL RA
Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574
Authors:
VORA A
MONAGHAN J
NUTTALL P
CROWTHER D
Citation: A. Vora et al., CYTOKINE-MEDIATED NITRIC-OXIDE RELEASE - A COMMON CYTOTOXIC PATHWAY IN HOST-VERSUS-GRAFT AND GRAFT-VERSUS-HOST REACTIONS, Bone marrow transplantation, 20(5), 1997, pp. 385-389
Authors:
SHARMA HL
COWAN RA
MURBY B
OWENS S
NUTTALL PM
GUNTON D
SMITH AM
CHANG J
CROWTHER D
Citation: Hl. Sharma et al., TREATMENT OF LYMPHOID-CELL MALIGNANCY WITH IN-114M LABELED AUTOLOGOUSLYMPHOCYTES, Anticancer research, 17(3B), 1997, pp. 1815-1821
Authors:
REYNOLDS A
MURRAY PI
MONAGHAN J
CROWTHER D
Citation: A. Reynolds et al., NITRIC-OXIDE METABOLITES IN HUMAN INFLAMMATORY EYE DISEASE, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2448-2448
Authors:
RUSTIN GJS
CROWTHER D
Citation: Gjs. Rustin et D. Crowther, GOOD MANNERS FOR THE PHARMACEUTICAL-INDUSTRY, Lancet, 350(9074), 1997, pp. 371-371
Authors:
DOBSON M
CARRINGTON BM
RADFORD JA
BUCKLEY CH
CROWTHER D
Citation: M. Dobson et al., THE ROLE OF COMPUTED-TOMOGRAPHY IN THE MANAGEMENT OF OVARIAN-TUMORS OF BORDERLINE MALIGNANCY, Clinical Radiology, 52(4), 1997, pp. 280-283
Authors:
LEE SM
RADFORD JA
RYDER WDJ
COLLINS CD
DEAKIN DP
CROWTHER D
Citation: Sm. Lee et al., PROGNOSTIC FACTORS FOR DISEASE PROGRESSION IN ADVANCED HODGKINS-DISEASE - AN ANALYSIS OF PATIENTS AGED UNDER 60 YEARS SHOWING PRO PROGRESSION IN THE FIRST 6 MONTHS AFTER STARTING PRIMARY CHEMOTHERAPY, British Journal of Cancer, 75(1), 1997, pp. 110-115
Authors:
RADFORD JA
LIEBERMAN BA
CRITCHLOW JD
GOSDEN RG
CROWTHER D
SHALET SM
Citation: Ja. Radford et al., CRYOPRESERVATION OF OVARIAN CORTICAL STRIPS BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) IN WOMEN DESIROUS OF FUTURE FERTILITY, Blood, 90(10), 1997, pp. 3940-3940
Authors:
RADFORD JA
CLARKE N
BROOK P
OCONNOR D
GOSDEN RG
CROWTHER D
SHALET SM
Citation: Ja. Radford et al., CRYOPRESERVATION OF SPERMATOGONIAL STEM-CELLS BEFORE CHEMOTHERAPY IN MEN DESIROUS OF FUTURE FERTILITY, Blood, 90(10), 1997, pp. 3941-3941
Authors:
KAMINSKI MS
VOSE J
SALEH M
LISTER A
KNOX S
CROWTHER D
ZELENETZ AD
COLCHER D
WAHL R
Citation: Ms. Kaminski et al., A MULTICENTER PHASE-II STUDY OF I-131 ANTI-B1 ANTIBODY (BEXXAR) IN PATIENTS (PTS) WITH CHEMOTHERAPY-RELAPSED REFRACTORY LOW-GRADE OR TRANSFORMED LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 2268-2268